Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct <i>OPA1</i> mutations and clinical pathologies.

Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct OPA1 mutations and clinical pathologies.

Pohl, Katherine A; Zhang, Xiangmei; Pham, Anh H; Chan, Jane W; Sadun, Alfredo A; Yang, Xian-Jie.

Afiliación

Pohl KA; Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States.
Zhang X; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, United States.
Pham AH; Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States.
Chan JW; Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States.
Sadun AA; Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States.
Yang XJ; Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Pasadena, CA, United States.

Front Genet ; 14: 1251216, 2023.

Article en En | MEDLINE | ID: mdl-37745862